SGLT2 Inhibitors for Diabetes Safe, Effective in Older Adults SGLT2 Inhibitors for Diabetes Safe, Effective in Older Adults

Real-world study suggests that they work just as well in adults aged 65 and older, although the genital-urinary infection rate was high.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news